Stoelzle Will Unveil Enhanced Pharma Glass in Milan
Pharmaceutical manufacturers will gain access to improved glass packaging technology for infusion therapies.
Updated on Sept. 22, 2026 in Consumer Goods
Live Poll
Will manufacturing innovations aimed at reducing waste lead to more reliable pharmaceutical products for patients?
Stoelzle Glass Group will debut an enhanced version of its EcoSecur pharmaceutical glass packaging at CPhI Worldwide 2026, which runs from October 6 to 8. This product update aims to improve hydrolytic resistance for injectable and infusion therapies.
Why it matters
The upgrade utilizes a refined liquid-injection manufacturing method designed to boost coating consistency and reduce production waste. This shift addresses the increasing operational need for high-stability materials that meet stringent pharmacopoeia standards.
The EcoSecur product line supports a range of bottle formats from 7 ml to 500 ml, providing options for various injectable and infusion therapies. The company is positioning this updated technology for a wider rollout following its initial market entry in 2021.
The players
Stoelzle Glass Group
An international manufacturer specializing in high-end glass packaging for the pharmaceutical, perfumery, and spirits sectors.
The details
The enhanced packaging is produced at Stoelzle's facility in Köflach, Austria, using Type 3 soda-lime glass treated on the inner surface. By using a liquid-injection method where treatment solution is applied via needles, the firm achieves more precise dosing. Automated process controls have been integrated to ensure production consistency and safety compliance with European and US pharmacopoeia requirements.
Timeline
EcoSecur originally became commercially available in 2021.
The CPhI Worldwide 2026 exhibition will take place from October 6 to 8.
Market Landscape
The exhibition at CPhI Worldwide remains the primary venue for introducing advancements in pharmaceutical containment technology. This development follows a multi-year industry trend toward enhanced hydrolytic resistance in glass packaging to ensure drug stability.
Supply chain managers should review their current glass packaging specifications to determine if this enhanced liquid-injection technology provides necessary stability gains for their injectable therapy lines. Operators should evaluate the compatibility of the 7 ml to 500 ml formats against their existing filling equipment.
The takeaway
Advancements in inner-surface treatment methods are enabling better compliance and reduced waste in pharmaceutical glass. Packaging managers should monitor technical data sheets post-exhibition to identify if these specific resistance improvements offer a viable replacement for existing materials.
What happens next
Stoelzle Glass Group will exhibit its new packaging solution at booth 11C74 during CPhI Worldwide 2026 in Milan, Italy.
Further reading
For more updates on container standards and manufacturing innovations, visit Consumer Goods.
Source note: This article includes information reported by Manufacturingchemist.
Live Poll
Will manufacturing innovations aimed at reducing waste lead to more reliable pharmaceutical products for patients?
